Кроме provisional market image, нашлись также final market image, current market formulation и clinical trial formulation. Судя по всему, речь идет о разных вариантах таблетки, отличающихся внешним видом и покрытием, причем final market image - окончательный вариант, предназначенный к реализации, а provisional, очевидно, - проектный, прототипный. Предлагаю "коммерческий/торговый прототип".

Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects
A final market image (FMI) tablet formulation of oxcarbazepine was compared with the marketed formulation (current market formulation (CMF)) and with the clinical trial formulation (CTF) tablet used during clinical efficacy and safety studies. The goal of the study was to compare the bioavailability after single doses and at steady state of the FM1 versus CMF and CTF as well.
...
These results clearly support the switch from the current market formulation (CMF) to the final market image tablet in the countries where Trileptal is or was already registered.
http://cat.inist.fr/?aModele=afficheN&cpsidt=13994393


Интересное замечание аскера в другой паре КудоЗ:

Color of the tablet, tablet shape, the debossed markings and waxing of the market image tablet are the only differences between clinical tablets and final market image tablets
http://www.proz.com/kudoz/english_to_spanish/medical:_pharma...